President Trump’s ongoing trade agenda, including fresh tariffs on semiconductors, autos, energy, and pharmaceuticals plus Canadian retaliatory measures effective September 8, continues to shape trader expectations for company mentions. Markets price roughly even odds across listed firms because historical patterns show Trump frequently naming specific companies exposed to duties or linked to onshoring pledges during speeches and roundtables. The September 12–13 Ireland trip for business-leader meetings and any follow-up diplomacy with China add near-term catalysts, while government equity stakes in firms like Intel and recent positive shout-outs for investments in U.S. facilities reinforce focus on sectors tied to administration policy. Outcomes remain sensitive to late-August developments carrying into the resolution window.